St. Louis startup developing cancer-fighting drug raises $21M By: St. Louis Business Journal via Business Journals April 06, 2022 at 15:12 PM EDT The St. Louis biotechnology startup plans to use its new funding to advance clinical trials of its lead drug candidate. Read More >> Related Stocks: Harbor Disruptive Innovation ETF
